
News|Articles|October 26, 2026
Counting down 2026’s top dvm360 articles #10-6
Author(s)Justin Louis, Content Producer
New treatment guidelines, a genetic first in cats, and fresh options in anesthesia make up the first half of our countdown of the year’s most-read stories.
Advertisement
Advertisement
From the exam room to the research lab, 2026 gave veterinary professionals plenty to read about. Updated guidelines changed the conversation around feline diabetes, a genetic first in cats made headlines, and practical advice on everything from kidney disease to antimicrobial stewardship kept readers coming back. Over the next 2 installments, we’re counting down the year’s top 10 dvm360 articles, starting with numbers 10 through 6.
Related to this article

New CATalyst Council data show cat visits growing for a third straight year. The bigger question for practices may be how many new kittens are still coming in as they age.

A new version of an injectable antibiotic, first approved in 2008, is approved only for dogs, as 2 of its inactive ingredients may be toxic to cats.

Alyssa Mages, CVT, FVTE, VTES, discusses catheter selection, common placement mistakes, and how preparation and hands-on practice can help veterinary technicians build confidence and improve patient care.

Practices in the United Kingdom will face a legal limit on prescription fees, plus new price list and estimate rules, under an order from the country's competition regulator.

Pamela D. Jones, DVM, DACVIM (Oncology), DACVR (Radiation Oncology), explains how the IDEXX Cancer Dx liquid biopsy test detects canine lymphoma, what its sensitivity and specificity mean in practice, and how to interpret a T-cell phenotype result.

A severely immunocompromised patient treated in Lyon died in early October. Investigators suspect the patient was bitten by an infected Culicoides midge in a region where the virus circulated in cattle this summer.

After more than 2 decades in clinical practice, a veterinary technician specialist shares how her hands-on experience with oncology studies led to a remote career monitoring veterinary clinical trials.
Advertisement
Advertisement

